WHODrug: A Global, Validated and Updated Dictionary for Medicinal Information.

Adverse event Clinical trial Drug coding Patient safety Pharmacovigilance Standardised Drug Groupings (SDG)

Journal

Therapeutic innovation & regulatory science
ISSN: 2168-4804
Titre abrégé: Ther Innov Regul Sci
Pays: Switzerland
ID NLM: 101597411

Informations de publication

Date de publication:
09 2020
Historique:
received: 23 12 2019
accepted: 09 02 2020
pubmed: 23 2 2020
medline: 3 6 2021
entrez: 21 2 2020
Statut: ppublish

Résumé

The WHODrug medicinal information dictionary is a worldwide source of global medicinal information with the aim to facilitate the coding of medications in clinical trials as well as identification of medication-related problems when monitoring patient safety, thereby supporting the development and usage of effective and safe medications. WHODrug contains individual trade names, active ingredients and additional information such as marketing authorisation holder, country of sale, pharmaceutical form and strength. All related medications are linked using a structured WHODrug alphanumeric code, connecting trade names and variation of the ingredient with the active moiety of the ingredient. Medications in WHODrug are classified using the ATC system and clustered into Standardised Drug Groupings, to allow for grouping of medications with one or more properties in common. The built-in data structure and the classification of medications in WHODrug facilitate various ways of aggregating medications for identification and analysis of possible adverse drug reactions. The different information levels in WHODrug are used to explore the relationship between a medication or a class of medications and an adverse event. By using WHODrug in clinical trials and post-marketing safety, accurate and standardised medication information can be achieved globally and allow easy information exchange. To meet the demands of WHODrug users from the pharmaceutical industry, academia and regulatory authorities, it is relevant to keep the dictionary comprehensive, validated and constantly updated on a global scale.

Identifiants

pubmed: 32078733
doi: 10.1007/s43441-020-00130-6
pii: 10.1007/s43441-020-00130-6
pmc: PMC7458889
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1116-1122

Références

Br J Clin Pharmacol. 2018 Aug;84(8):1858-1859
pubmed: 29797731
Perspect Clin Res. 2010 Jan;1(1):29-32
pubmed: 21829779
Perspect Clin Res. 2013 Jul;4(3):181-5
pubmed: 24010060
Drug Saf. 2019 Dec;42(12):1393-1407
pubmed: 31446567
Drug Saf. 2015 Apr;38(4):373-82
pubmed: 25687792
Contemp Clin Trials. 2010 Jan;31(1):108-18
pubmed: 19900576
Drug Saf. 2010 Jul 1;33(7):e1-e23
pubmed: 20553053
Br J Clin Pharmacol. 2018 May;84(5):1072-1074
pubmed: 29512176
Pharmacoepidemiol Drug Saf. 2019 May;28(5):680-689
pubmed: 30767342
Birth Defects Res C Embryo Today. 2015 Jun;105(2):140-56
pubmed: 26043938
Methods Inf Med. 1974 Jul;13(3):169-78
pubmed: 4607443
Drug Saf. 2019 Dec;42(12):1487-1498
pubmed: 31559542

Auteurs

Olof Lagerlund (O)

Uppsala Monitoring Centre, Box 1051, 751 40, Uppsala, Sweden. Olof.lagerlund@who-umc.org.

Sara Strese (S)

Uppsala Monitoring Centre, Box 1051, 751 40, Uppsala, Sweden.

Malin Fladvad (M)

Uppsala Monitoring Centre, Box 1051, 751 40, Uppsala, Sweden.

Marie Lindquist (M)

Uppsala Monitoring Centre, Box 1051, 751 40, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH